Second-Line Endocrine Therapy With or Without PalbociclibRechallenge in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–NegativeAdvanced Breast Cancer: PALMIRA Trial

Beta blocker use and breast cancer survival by subtypes: Apopulation-based cohort study